Entera Bio Ltd.
Entera Bio Ltd.（ENTX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
entx · 股价预测 · 4 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 4 位华尔街分析师
Buy
4 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.20
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.18 | ↓ 1.57% |
1-day model range: $1.17–$1.19. Peak: $1.19 (-1.57%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -37.0% |
| 2028 | $1 | -48.7% |
| 2029 | $1 | -53.5% |
| 2030 | $1 | -55.6% |
| 2031 | — | -56.6% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ENTX · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-09-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Entera Bio Ltd. (ENTX) stock. Of the recent 22 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover ENTX.
分析师推荐趋势
ENTX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↑ 35.7% YoY
Revenue Next Year
$0M
↑ 143.9% YoY
EPS This Year
$-0.26
EPS Next Year
$-0.28
↑ 8.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast ENTX EPS of $-0.26 for the current fiscal year, based on estimates from 1 analysts. The ENTX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ENTX 股价预测由两类独立数据源支撑：来自 4 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ENTX 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
ENTX 的短期预测（明日）为 $1.18（-1.57%）。 ENTX 对 2027 年的股价预测均值为 $1。 ENTX 对 2030 年的预测区间为 $0–$1。
Entera Bio Ltd. 在 NASDAQ 上市，代码 ENTX。ENTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
ENTX 预测 · 8 个问题根据 4 位华尔街分析师，ENTX 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $1.20，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.